European Immunization Week 2018- Statement of Guido Rasi, Executive Director, European Medicines Agency

Posted on: 26/04/2018 - 13:27

Vaccines matter for each of us: yearly, they prevent 2.7 million people from contracting measles, one million from getting whooping cough and two million babies from getting tetanus. They eradicated smallpox. They stopped polio, a dreadful disease affecting millions of children, in almost all... more

Field of Interest: European Union Medical News
Type: News Feed

Human medicines European public assessment report (EPAR): Nuwiq, simoctocog alfa, Date of authorisation: 22/07/2014, Revision: 14, Status: Authorised

Submitted by Anonymous (not verified) on 21 May 2026 - 14:40

Human medicines European public assessment report (EPAR): Nuwiq, simoctocog alfa, Date of authorisation: 22/07/2014, Revision: 14, Status: Authorised

Human medicines European public assessment report (EPAR): Zoledronic acid Teva, zoledronic acid, Date of authorisation: 16/08/2012, Revision: 16, Status: Authorised

Submitted by Anonymous (not verified) on 21 May 2026 - 14:32

Human medicines European public assessment report (EPAR): Zoledronic acid Teva, zoledronic acid, Date of authorisation: 16/08/2012, Revision: 16, Status: Authorised

Human medicines European public assessment report (EPAR): Bavencio, avelumab, Date of authorisation: 18/09/2017, Revision: 23, Status: Authorised

Submitted by Anonymous (not verified) on 21 May 2026 - 14:25

Human medicines European public assessment report (EPAR): Bavencio, avelumab, Date of authorisation: 18/09/2017, Revision: 23, Status: Authorised

Human medicines European public assessment report (EPAR): Exjade, deferasirox, Date of authorisation: 28/08/2006, Revision: 58, Status: Authorised

Submitted by Anonymous (not verified) on 21 May 2026 - 13:36

Human medicines European public assessment report (EPAR): Exjade, deferasirox, Date of authorisation: 28/08/2006, Revision: 58, Status: Authorised

Human medicines European public assessment report (EPAR): Ceprotin, human protein C, Date of authorisation: 16/07/2001, Revision: 21, Status: Authorised

Submitted by Anonymous (not verified) on 21 May 2026 - 13:30

Human medicines European public assessment report (EPAR): Ceprotin, human protein C, Date of authorisation: 16/07/2001, Revision: 21, Status: Authorised

Human medicines European public assessment report (EPAR): Kisqali, ribociclib, Date of authorisation: 22/08/2017, Revision: 26, Status: Authorised

Submitted by Anonymous (not verified) on 21 May 2026 - 13:25

Human medicines European public assessment report (EPAR): Kisqali, ribociclib, Date of authorisation: 22/08/2017, Revision: 26, Status: Authorised

Newsletters

Stay informed on our latest news!

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Latest Newsletters

More